Results 251 to 260 of about 303,803 (298)
Some of the next articles are maybe not open access.
Molecular Genetics of Pancreatic Neoplasms
Surgical Pathology Clinics, 2016Pancreatic neoplasms have a wide range of histologic types with distinct clinical outcomes. Recent advances in high-throughput sequencing technologies have greatly deepened our understanding of pancreatic neoplasms. Now, the exomes of major histologic types of pancreatic neoplasms have been sequenced, and their genetic landscapes have been revealed ...
Waki Hosoda, Laura D Wood
exaly +3 more sources
Gastroenterology Clinics of North America, 2022
Early detection of high-risk pancreatic cystic lesions enables potentially curative surgical resection, and early detection of lesions without worrisome features may lead to appropriate surveillance. Regrettably, differentiating premalignant and malignant cysts from nonmalignant ones remains challenging.
Sahin, Coban +2 more
openaire +2 more sources
Early detection of high-risk pancreatic cystic lesions enables potentially curative surgical resection, and early detection of lesions without worrisome features may lead to appropriate surveillance. Regrettably, differentiating premalignant and malignant cysts from nonmalignant ones remains challenging.
Sahin, Coban +2 more
openaire +2 more sources
Gastrointestinal Endoscopy Clinics of North America, 2005
Patients who present with signs and symptoms suggesting a pancreatic neoplasm typically undergo initial imaging with transabdominal ultrasound or CT. When a pancreatic mass or fullness is identified, it may represent an inflammatory mass, benign process, or malignancy. Endoscopic ultrasound (EUS) is performed commonly to further characterize the lesion,
Michael J, Levy, Maurits J, Wiersema
openaire +3 more sources
Patients who present with signs and symptoms suggesting a pancreatic neoplasm typically undergo initial imaging with transabdominal ultrasound or CT. When a pancreatic mass or fullness is identified, it may represent an inflammatory mass, benign process, or malignancy. Endoscopic ultrasound (EUS) is performed commonly to further characterize the lesion,
Michael J, Levy, Maurits J, Wiersema
openaire +3 more sources
Surgical Clinics of North America, 2010
Cystic neoplasms of the pancreas have been recognized for almost 2 centuries, but the principles of management continue to evolve. Clinicians have a better understanding now of the diverse pathologies and behaviors of cystic neoplasms, and can characterize them more precisely into benign, malignant, and of uncertain potential in their manifestations ...
Jennifer E, Verbesey, J Lawrence, Munson
openaire +4 more sources
Cystic neoplasms of the pancreas have been recognized for almost 2 centuries, but the principles of management continue to evolve. Clinicians have a better understanding now of the diverse pathologies and behaviors of cystic neoplasms, and can characterize them more precisely into benign, malignant, and of uncertain potential in their manifestations ...
Jennifer E, Verbesey, J Lawrence, Munson
openaire +4 more sources
Current Opinion in Gastroenterology, 2003
This review describes significant basic science and clinical advances in the field of pancreatic neoplasms.Some of the genetic and molecular bases for the aggressive behavior of pancreatic cancer have been uncovered, and new targets for therapy have been identified.
John P, Duffy, Howard A, Reber
openaire +2 more sources
This review describes significant basic science and clinical advances in the field of pancreatic neoplasms.Some of the genetic and molecular bases for the aggressive behavior of pancreatic cancer have been uncovered, and new targets for therapy have been identified.
John P, Duffy, Howard A, Reber
openaire +2 more sources
Current Opinion in Gastroenterology, 2004
This review includes a summary of articles that have affected the study and treatment of pancreatic neoplasms over the past year.Over the past year, there have been several reports of new animal models of pancreatic cancer that recapitulate the human disease and hold promise for preclinical studies.
Oscar J, Hines, Howard A, Reber
openaire +2 more sources
This review includes a summary of articles that have affected the study and treatment of pancreatic neoplasms over the past year.Over the past year, there have been several reports of new animal models of pancreatic cancer that recapitulate the human disease and hold promise for preclinical studies.
Oscar J, Hines, Howard A, Reber
openaire +2 more sources
Pancreatic Neoplasms and Autophagy
Current Drug Targets, 2018Pancreatic cancer is predicted to be the second deadliest malignancy (a median survival of 4-6 months and a 5-year survival of less than 5%) in the USA by 2020. Although current medical detection technologies have dramatically improved the survival rate for patients with other gastrointestinal malignancies, the dismal clinical outcome remains somewhat ...
Linzi A, Barton, Jun, Ren
openaire +2 more sources
Imaging of Pancreatic Neoplasms
Surgical Oncology Clinics of North America, 2014Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery.
Aparna, Balachandran +3 more
openaire +2 more sources
Pancreatic Neuroendocrine Neoplasms
Surgical Pathology Clinics, 2014Pancreatic neuroendocrine neoplasms (Pan-NENs) are rare but clinically important lesions. Pan-NENs are known for and often categorized by their capacity to produce clinical syndromes mediated by the production of hormones. Despite sometimes presenting dramatically from excessive hormone production, not all Pan-NENs produce functional hormone, and they ...
J N, Rosenbaum, Ricardo Vincent, Lloyd
openaire +2 more sources